Mesh.i
Exploration
Accueil
Racine
Exploration
Accueil
Racine

La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Mesh.i » - entrée « Monoamine Oxidase Inhibitors »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Monoamine Oxidase < Monoamine Oxidase Inhibitors < Monocytes  Facettes :

List of bibliographic references indexed by Monoamine Oxidase Inhibitors

Number of relevant bibliographic references: 19.
Ident.Authors (with country if any)Title
000249 (2016) Fariborz Rahimi [Iran] ; Angela C. Roberts [États-Unis] ; Mandar Jog [Canada]Patterns and predictors of freezing of gait improvement following rasagiline therapy: A pilot study.
000413 (2016) John L. Goudreau [États-Unis] ; Adriana Pérez [États-Unis] ; Michael J. Aminoff [États-Unis] ; James T. Boyd [États-Unis] ; Keith D. Burau [États-Unis] ; Chadwick W. Christine [États-Unis] ; Maureen Leehey [États-Unis] ; John C. Morgan [États-Unis]Choice of dopaminergic therapy among early, mild Parkinson disease subjects in North America.
000483 (2015) James A. G. Crispo [États-Unis] ; Yannick Fortin ; Dylan P. Thibault [États-Unis] ; Matthew Emons [États-Unis] ; Lise M. Bjerre ; Dafna E. Kohen ; Santiago Perez-Lloret [Argentine] ; Donald Mattison ; Allison W. Willis [États-Unis] ; Daniel KrewskiTrends in inpatient antiparkinson drug use in the USA, 2001–2012
000932 (2014) Michel Panisset [Canada] ; Jack J. Chen ; Sean H. Rhyee ; Jill Conner ; Julie MathenaSerotonin toxicity association with concomitant antidepressants and rasagiline treatment: retrospective study (STACCATO).
000A30 (2014) Anthony E. Lang [Canada] ; Connie Marras [Canada]Initiating dopaminergic treatment in Parkinson's disease.
000D19 (2013) Susan H. Fox [Canada]Non-dopaminergic treatments for motor control in Parkinson's disease.
001142 (2012) Sheridan M. Hoy [Nouvelle-Zélande] ; Gillian M. KeatingRasagiline: a review of its use in the treatment of idiopathic Parkinson's disease.
002133 (2008) Quincy J. Almeida [Canada] ; H Christopher HysonThe evolution of pharmacological treatment for Parkinson's disease.
002441 (2007) Vicki Oldfield [États-Unis] ; Gillian M. Keating ; Caroline M. PerryRasagiline: a review of its use in the management of Parkinson's disease.
002A01 (2005) Tom H. Johnston [Canada] ; Susan H. Fox ; Jonathan M. BrotchieAdvances in the delivery of treatments for Parkinson's disease.
002C02 (2004) A controlled, randomized, delayed-start study of rasagiline in early Parkinson disease.
002F63 (2002) Andreas Kupsch [Allemagne]Rasagiline. Teva Pharmaceutical.
003453 (2000) Andis Klegeris [Canada] ; Patrick L. Mcgeer [Canada]R -(−)-Deprenyl Inhibits Monocytic THP-1 Cell Neurotoxicity Independently of Monoamine Oxidase Inhibition
003628 (1999) T L Sourkes [Canada]"Rational hope" in the early treatment of Parkinson's disease.
003741 (1999) Line Ste-Marie [Canada] ; Luc Vachon [Canada] ; Chantal Bémeur [Canada] ; Jean Lambert [Canada] ; Jane Montgomery [Canada]Local striatal infusion of MPP+ does not result in increased hydroxylation after systemic administration of 4-hydroxybenzoate
003865 (1998) A A Boulton [Canada] ; G. EisenhoferCatecholamine metabolism. From molecular understanding to clinical diagnosis and treatment. Overview.
003D02 (1996) W G Tatton [Canada] ; J S Wadia ; W Y Ju ; R M Chalmers-Redman ; N A Tatton(-)-Deprenyl reduces neuronal apoptosis and facilitates neuronal outgrowth by altering protein synthesis without inhibiting monoamine oxidase.
004157 (1994) M. D. Berry [Canada] ; A. V. Juorio [Canada] ; I. A. Paterson [Canada]Possible mechanisms of action of (−)deprenyl and other MAO-B inhibitors in some neurologic and psychiatric disorders
004159 (1994) Peter H. Yu [Canada]Pharmacological and clinical implications of MAO-B inhibitors

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Monoamine Oxidase Inhibitors" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Monoamine Oxidase Inhibitors" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Monoamine Oxidase Inhibitors
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022